These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 8392414

  • 1. Bubble-induced aggregation of platelets: effects of gas species, proteins, and decompression.
    Thorsen T, Klausen H, Lie RT, Holmsen H.
    Undersea Hyperb Med; 1993 Jun; 20(2):101-19. PubMed ID: 8392414
    [Abstract] [Full Text] [Related]

  • 2. Transmission and scanning electron microscopy of N2 microbubble-activated human platelets in vitro.
    Thorsen T, Dalen H, Bjerkvig R, Holmsen H.
    Undersea Biomed Res; 1987 Jan; 14(1):45-58. PubMed ID: 3810992
    [Abstract] [Full Text] [Related]

  • 3. A method for production of N2 microbubbles in platelet-rich plasma in an aggregometer-like apparatus, and effect on the platelet density in vitro.
    Thorsen T, Brubakk A, Ovstedal T, Farstad M, Holmsen H.
    Undersea Biomed Res; 1986 Sep; 13(3):271-88. PubMed ID: 3775967
    [Abstract] [Full Text] [Related]

  • 4. Induction of platelet aggregation in vitro by microbubbles of nitrogen.
    Thorsen T, Lie RT, Holmsen H.
    Undersea Biomed Res; 1989 Nov; 16(6):453-64. PubMed ID: 2603242
    [Abstract] [Full Text] [Related]

  • 5. Gel-filtered human platelets. Ultrastructure, function, and role of proteins in inhibition of aggregation by aspirin.
    Fine KM, Ashbrook PC, Brigden LP, Maldonado JE, Didishelm P.
    Am J Pathol; 1976 Jul; 84(1):11-24. PubMed ID: 59550
    [Abstract] [Full Text] [Related]

  • 6. Effects of platelet antagonists on the reduction in platelet density caused by microbubbles in vitro.
    Thorsen T, Ovstedal T, Vereide A, Holmsen H.
    Undersea Biomed Res; 1986 Sep; 13(3):289-303. PubMed ID: 3022436
    [Abstract] [Full Text] [Related]

  • 7. Detection of P2Y(14) protein in platelets and investigation of the role of P2Y(14) in platelet function in comparison with the EP(3) receptor.
    Dovlatova N, Wijeyeratne YD, Fox SC, Manolopoulos P, Johnson AJ, White AE, Latif ML, Ralevic V, Heptinstall S.
    Thromb Haemost; 2008 Aug; 100(2):261-70. PubMed ID: 18690346
    [Abstract] [Full Text] [Related]

  • 8. Spontaneous platelet aggregation in a hereditary giant platelet syndrome (MPS).
    Milton JG, Frojmovic MM, Tang SS, White JG.
    Am J Pathol; 1984 Feb; 114(2):336-45. PubMed ID: 6696046
    [Abstract] [Full Text] [Related]

  • 9. Influence of extracellular calcium on single platelet activation as measured by whole blood flow cytometry.
    Hu H, Forslund M, Li N.
    Thromb Res; 2005 Feb; 116(3):241-7. PubMed ID: 15935833
    [Abstract] [Full Text] [Related]

  • 10. The effect of tirofiban on fibrinogen/agonist-induced platelet shape change and aggregation.
    Jagroop IA, Mikhailidis DP.
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):295-302. PubMed ID: 18445610
    [Abstract] [Full Text] [Related]

  • 11. Effects of cytochalasin H, a potent inhibitor of cytoskeletal reorganisation, on platelet function.
    Natarajan P, May JA, Sanderson HM, Zabe M, Spangenberg P, Heptinstall S.
    Platelets; 2000 Dec; 11(8):467-76. PubMed ID: 11177446
    [Abstract] [Full Text] [Related]

  • 12. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents.
    Lages B, Weiss HJ.
    Thromb Haemost; 1981 Apr 30; 45(2):173-9. PubMed ID: 6789496
    [Abstract] [Full Text] [Related]

  • 13. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M, Banno Y, Naganawa T.
    Platelets; 2005 Dec 30; 16(8):482-91. PubMed ID: 16287615
    [Abstract] [Full Text] [Related]

  • 14. Alternate complement pathway induction of aggregation and release of 5-hydroxytryptamine and adenosine diphosphate by rabbit platelets.
    Marney SR, Colley DG, Des Prez RM.
    J Immunol; 1975 Feb 30; 114(2 Pt 1):696-703. PubMed ID: 804512
    [Abstract] [Full Text] [Related]

  • 15. Effects of P2Y(1) and P2Y(12) receptor antagonists on ADP-induced shape change of equine platelets: comparison with human platelets.
    Mateos-Trigos G, Evans RJ, Heath MF.
    Platelets; 2002 Feb 30; 13(5-6):285-92. PubMed ID: 12189014
    [Abstract] [Full Text] [Related]

  • 16. Intravascular bubble composition in guinea pigs: a possible explanation for differences in decompression risk among different gases.
    Lillo RS, Maccallum ME, Caldwell JM.
    Undersea Biomed Res; 1992 Sep 30; 19(5):375-86. PubMed ID: 1355314
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of platelet function, a method comparison.
    Nylander S, Johansson K, Van Giezen JJ, Lindahl TL.
    Platelets; 2006 Feb 30; 17(1):49-55. PubMed ID: 16308187
    [Abstract] [Full Text] [Related]

  • 18. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM, Kasirer-Friede A, Goldsmith HL, Brown EA.
    Thromb Haemost; 1997 Mar 30; 77(3):568-76. PubMed ID: 9066012
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM, Reininger AJ, Toth O, Deckmyn H, Brandl R, Siess W.
    Thromb Haemost; 2007 Mar 30; 97(3):435-43. PubMed ID: 17334511
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.